Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapy for β-thalassemia major (TM) and sickle cell disease (SCD) in children. Graft-versus-host disease (GVHD) and treatment-related mortality (TRM) remain significant challenges to improving survival after HSCT. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Bo-Kyoung, Kim, Hyo-Sup, Kim, Seongkoo, Lee, Jae-Wook, Park, Young Shil, Jang, Pil-Sang, Chung, Nack-Gyun, Jeong, Dae-Chul, Cho, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021564/
https://www.ncbi.nlm.nih.gov/pubmed/29963521
http://dx.doi.org/10.5045/br.2018.53.2.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021564/
https://www.ncbi.nlm.nih.gov/pubmed/29963521
http://dx.doi.org/10.5045/br.2018.53.2.145

Ejemplares similares